We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+5.01%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.71B
AUM Growth
+$31.6M
(+1.9%)
Cap. Flow
-$34.4M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
586
New
76
Increased
162
Reduced
181
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Value ETF
IWN
|
+$58.4M |
| 2 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$8.89M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$8.58M |
| 4 |
Check Point Software Technologies
CHKP
|
+$7.27M |
| 5 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$5.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$58.9M |
| 2 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$11.2M |
| 3 |
Credicorp
BAP
|
+$8.21M |
| 4 |
Alibaba
BABA
|
+$5.31M |
| 5 |
Schwab US Large- Cap ETF
SCHX
|
+$5.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.28% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 6.23% |
| 4 | Communication Services | 5.69% |
| 5 | Industrials | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Quest Diagnostics
DGX
$23.2B
| $3.71M | 0.22% |
34,415
-476
| -1% | -$52.2K |
|
102
HubSpot
HUBS
$10.5B
| $3.59M | 0.21% |
23,800
-1,700
| -7% | -$234K |
|
103
Gilead Sciences
GILD
$162B
| $3.56M | 0.21% |
46,167
-1,352
| -3% | -$102K |
|
104
iShares S&P 500 Growth ETF
IVW
$74.2B
| $3.55M | 0.21% |
80,196
-2,568
| -3% | -$110K |
|
105
iShares S&P 100 ETF
OEF
$20.1B
| $3.55M | 0.21% |
27,404
-315
| -1% | -$39.8K |
|
106
iShares S&P 500 Value ETF
IVE
$48.8B
| $3.54M | 0.21% |
30,574
-975
| -3% | -$112K |
|
107
Euronet Worldwide
EEFT
$2.97B
| $3.52M | 0.21% |
35,142
+142
| +0.4% | +$13.4K |
|
108
Intel
INTC
$516B
| $3.52M | 0.21% |
74,352
+6,802
| +10% | +$331K |
|
|
TSE
109
DELISTED
Trinseo
TSE
| $3.51M | 0.21% |
44,793
+697
| +2% | +$52.2K |
|
110
Wyndham Hotels & Resorts
WH
$5.67B
| $3.46M | 0.2% |
62,217
+17,422
| +39% | +$997K |
|
111
Lockheed Martin
LMT
$119B
| $3.42M | 0.2% |
9,884
+9,074
| +1,120% | +$2.93M |
|
|
MXIM
112
DELISTED
Maxim Integrated Products
MXIM
| $3.35M | 0.2% |
59,484
| – | – |
|
|
CELG
113
DELISTED
Celgene Corp
CELG
| $3.34M | 0.2% |
37,322
-4,661
| -11% | -$412K |
|
114
Dana Inc
DAN
$3.02B
| $3.32M | 0.19% |
177,928
+143,928
| +423% | +$2.9M |
|
115
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $3.29M | 0.19% |
76,760
+17
| +0% | +$734 |
|
|
ORBK
116
DELISTED
Orbotech Ltd
ORBK
| $3.29M | 0.19% |
55,400
| – | – |
|
117
Lam Research
LRCX
$399B
| $3.26M | 0.19% |
214,830
-4,280
| -2% | -$73.1K |
|
118
iShares Floating Rate Bond ETF
FLOT
$10.1B
| $3.19M | 0.19% |
+62,480
| New | +$3.18M |
|
119
Packaging Corp of America
PKG
$20.3B
| $3.17M | 0.19% |
28,856
+350
| +1% | +$39.5K |
|
|
TECD
120
DELISTED
Tech Data Corp
TECD
| $3.12M | 0.18% |
43,650
+5,550
| +15% | +$450K |
|
121
Cognizant
CTSH
$20.4B
| $3.12M | 0.18% |
40,394
+239
| +0.6% | +$18.7K |
|
122
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
| $3.05M | 0.18% |
118,794
-32,250
| -21% | -$836K |
|
123
Cummins
CMI
$91.2B
| $3.05M | 0.18% |
20,871
-1,513
| -7% | -$213K |
|
124
Applied Materials
AMAT
$440B
| $3.02M | 0.18% |
78,000
-1,730
| -2% | -$76.5K |
|
125
Qualys
QLYS
$4.94B
| $2.99M | 0.18% |
33,600
| – | – |
|
Similar funds
EC
SFM
NHC
EQF
CCM
NEI
Bailard's Q3 2018 Portfolio in Review
As of Q3 2018, Bailard held 586 positions worth $1.71B, up 1.9% from $1.68B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bailard's Q3 2018 filing shows 76 new, 162 increased, 181 reduced and 60 closed positions. Its largest new stake was Teva Pharmaceuticals: 369,700 shares worth $7.96M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q3 2018 buy was Teva Pharmaceuticals: 369,700 shares worth $7.96M.
- Bailard added most to iShares Russell 2000 Value ETF in Q3 2018, an estimated $58.4M increase.
- Bailard's biggest Q3 2018 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.9M.
- Bailard fully exited Mercado Libre in Q3 2018, selling an estimated $3.89M.
- Bailard's ten largest holdings make up 33% of its $1.71B portfolio in Q3 2018.
- Bailard opened 76 new positions and closed 60 in Q3 2018.
- Bailard's portfolio value rose 1.9% quarter-over-quarter to $1.71B.
Based on Bailard's 13F filing for Q3 2018, filed 13 Nov 2018.